INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

576 studies · page 4 of 24

2018 / Within-subject comparative study with washout

Diet restriction alone achieved similar short-term glycemic and insulin improvements as RYGB combined with the same diet in patients with type 2 diabetes.

Ten patients with type 2 diabetes completed a 10-day supervised peri-operative-equivalent diet intervention, followed by a washout period, and then an identical diet paired with RYGB. Both interventions produced similar improvements in glucose levels, β-cell function, insulin sensitivity, and post-meal hepatic insulin resistance, alongside significant decreases in fasting and postprandial acyl ghrelin. The diet-only period led to greater improvements in basal hepatic glucose output and post-meal GIP secretion, whereas the diet plus RYGB intervention induced significantly greater increases in post-meal GLP-1, PYY, and glucagon levels.

Pop LM, Mari A, Zhao TJ, et al. Diabetes Obes Metab, 2018. PMID 29532631

2018 / Double-blind, crossover, randomized, placebo-controlled trial

Combined resveratrol and curcumin supplementation did not alter the postprandial inflammatory response to a high-fat meal in older adults with abdominal obesity.

In a randomized, double-blind crossover trial, 22 older adults with abdominal obesity underwent a 6-hour oral fat tolerance test after consuming either a supplement (200 mg resveratrol and 100 mg curcumin) or a placebo. Supplementation did not modify postprandial variations in circulating inflammatory markers (CRP, IL-6, IL-8, MCP-1) or adhesion molecules (sE-selectin, sVCAM-1, sICAM-1) compared to placebo (P Treatment×Time > 0.05). However, the supplement significantly reduced the cumulative postprandial response of sVCAM-1 (incremental area under the curve -4643%, P = 0.01), while whole-blood PPARA and NFKB1 gene expressions were unchanged.

Vors C, Couillard C, Paradis ME, et al. J Nutr, 2018. PMID 29546309

2018 / Double-blind, randomized crossover trial

TA-65 supplementation improved HDL-C, LDL/HDL ratio, BMI, waist circumference, and TNF-alpha in patients with metabolic syndrome.

A double-blind, randomized crossover trial evaluated the effects of 16 mg daily of TA-65 (an Astragalus membranaceus extract) versus placebo for 12 weeks with a 3-week washout in 40 patients with metabolic syndrome. Compared to placebo, TA-65 treatment led to significantly higher HDL-C and lower BMI, waist circumference, LDL/HDL ratio, and plasma TNF-alpha (p < 0.05 for all). Changes in HDL-C between periods were negatively correlated with changes in CRP (r = -0.511, p < 0.01), ALT (r = -0.61, p < 0.001), and TNF-alpha (r = -0.550, p < 0.001).

Fernandez ML, Thomas MS, Lemos BS, et al. Curr Pharm Des, 2018. PMID 29546832

2018 / Uncontrolled before-and-after intervention study

A 4-week defined plant-based diet reduced blood pressure, serum lipids, and medication usage in an outpatient clinic setting.

Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).

Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002

2018 / Randomized controlled trial

Sustained calorie restriction over two years induced metabolic adaptation and lowered oxidative stress.

A randomized trial assigned 53 non-obese adults to either approximately 15% calorie restriction (n = 34) or a control group (n = 19) for two years. Participants in the restriction group lost an average of 8.7 kg, while control participants gained 1.8 kg. Measured daily energy expenditure was 80 to 120 kcal lower than predicted from weight loss, accompanied by decreased thyroid axis activity and lower F2-isoprostane levels.

Redman LM, Smith SR, Burton JH, et al. Cell Metab, 2018. PMID 29576535

2018 / Randomized controlled trial

Powdered Nigella sativa improved body weight, BMI, and lipid profiles in patients with Hashimoto's thyroiditis.

Forty patients with Hashimoto's thyroiditis aged 22-50 were randomized to receive powdered Nigella sativa or placebo daily for 8 weeks. Treatment with Nigella sativa significantly reduced body weight and body mass index, decreased serum LDL and triglyceride concentrations, and significantly increased HDL cholesterol (P < 0.05), while no such changes were seen in the placebo group. Serum Nesfatin-1 was inversely associated with triglycerides (r = -0.31, P = 0.04).

Farhangi MA, Dehghan P, Tajmiri S Lipids Health Dis, 2018. PMID 29587770

2018 / Validation study using data from a 2-year trial

The NIH Body Weight Planner accurately simulated average weight loss from calorie restriction, outperforming the PBRC Weight Loss Predictor.

Researchers compared two mathematical models underlying web-based weight-loss prediction tools (NIH BWP and PBRC WLP) against data from the 2-year CALERIE study of calorie restriction. The PBRC WLP model simulated an exaggerated early drop in energy expenditure, substantially underestimating observed mean weight loss by 3.8 (95% CI: 3.5, 4.2) kg. In contrast, the NIH BWP model showed much closer alignment with data, having an overall mean ΔBW bias of -0.47 (-0.92, -0.015) kg. However, both models exhibited substantial variability in simulating individual outcomes.

Guo J, Brager DC, Hall KD Am J Clin Nutr, 2018. PMID 29635495

2018 / Crossover trial

A single 45-minute aerobic exercise session reduced postprandial glucose and insulin and improved insulin sensitivity in normal weight and overweight adolescents.

Researchers evaluated the effect of a 45-minute aerobic exercise session performed either 17 hours prior (Prior Day Ex) or 40 minutes prior (Same Day Ex) versus no exercise on postprandial glucose control following a test meal in 11 normal weight and 12 overweight/obese adolescents. Across all trials, the overweight/obese group had higher fasting glucose (~6%) and insulin (~66%), and lower insulin sensitivity (~9%) than normal weight peers. Both Same Day Ex and Prior Day Ex reduced glucose area under the curve by 6% (P < .01), reduced insulin AUC by 15% and 13% respectively (P < .03), and increased insulin sensitivity by 8% and 6% respectively (P < .01). The magnitude of these effects did not differ between normal weight and overweight/obese groups.

Short KR, Pratt LV, Teague AM Pediatr Diabetes, 2018. PMID 29687558

2018 / Experimental crossover trial

Chewing gum while walking increased heart rate, walking distance, speed, steps, and energy expenditure depending on sex and age.

This study evaluated 46 male and female participants aged 21-69 years who walked at natural paces for 15 minutes while chewing two gum pellets versus ingesting powder with the same ingredients excluding the gum base. Heart rates during walking and heart rate changes from rest significantly increased in the gum trial compared with the control trial. Male participants experienced significantly higher walking distance, speed, heart rate, and heart rate changes with gum chewing, while female participants showed significantly higher walking heart rate and heart rate changes. In male participants aged ≥40 years, walking distance, walking speed, steps, and energy expenditure were significantly increased in the gum trial compared with the control trial.

Hamada Y, Yanaoka T, Kashiwabara K, et al. J Phys Ther Sci, 2018. PMID 29706720

2018 / Single-blinded randomized controlled trial

Flaxseed cookies improved constipation symptoms, body weight, glycemic control, and lipid levels in constipated patients with type 2 diabetes.

In a single-blinded randomized controlled trial, 53 constipated patients with type 2 diabetes received either 10 g of flaxseed pre-mixed in cookies twice daily or placebo cookies for 12 weeks. Compared with placebo, the flaxseed group showed statistically significant improvements in absolute change for constipation symptom scores (2.46 vs. 0.41), weight (-3.8 vs. 0.0 kg), BMI (-1.5 vs. -0.1 kg/m2), FPG (-26.7 vs. -1.9 mg/dl), HbA1c (-0.8 vs. 1.0%), cholesterol (-37.3 vs. -10.4 mg/dl), LDLC (-21.0 vs. -4.3 mg/dl), and HDLC (4.7 vs. -4.4 mg/dl; all P < 0.05). Compliance was reported as good, and no adverse effects were observed.

Soltanian N, Janghorbani M Nutr Metab (Lond), 2018. PMID 29760761

2018 / Randomized controlled trial

Intermittent and continuous calorie restriction produced comparable 1-year weight loss.

In a 1-year randomized trial, 112 adults with abdominal obesity underwent 6 months of active weight loss followed by 6 months of maintenance. Average weight loss was 8.0 kg (SD 6.5) with intermittent restriction and 9.0 kg (SD 7.1) with continuous restriction (p = 0.6), and weight regain was similar (1.1 kg vs 0.4 kg). Both diets improved blood pressure, waist circumference, triglycerides, and HDL cholesterol equally, though the intermittent group reported higher hunger scores (4.7 vs 3.6, p = 0.002).

Sundfør TM, Svendsen M, Tonstad S Nutr Metab Cardiovasc Dis, 2018. PMID 29778565

2018 / Three-arm randomized controlled trial

Financial incentives did not provide additional benefits for weight loss maintenance compared to active text-message feedback alone.

Researchers randomized 191 adults who recently lost at least 5 kg to daily self-weighing and text feedback alone (control), combined with a lottery-based incentive, or combined with a direct incentive for 6 months, followed by 6 months of passive monitoring. Mean weight changes during the first 6 months were -3.0 kg for lottery, -2.8 kg for direct, and -1.4 kg for control (all pairwise comparisons p > 0.1). At 12 months, weight changes were -1.8 kg for lottery, -0.7 kg for direct, and -0.3 kg for control (p > 0.1). Across all arms, there were no significant differences in the proportion maintaining weight loss or in self-reported physical activity and eating behaviors.

Yancy WS, Shaw PA, Wesby L, et al. Nutr Diabetes, 2018. PMID 29795365

2018 / Randomized crossover trial

A 2-day very low-calorie diet in obese young women evoked moderate stress, altered specific cognitive functions, and did not affect autonomic function or mood.

Nine obese women aged 22-31 years were tested under two randomly allocated conditions: a 2-day very low-calorie diet (511 kcal) and a 2-day usual diet. The calorie-restricted diet received a subjective stress rating of 41.5 ± 23.3, but had no detectable effects on heart rate variability indices, mood, grip strength, or psychomotor functions. However, calorie restriction significantly increased spatial processing and visuospatial working memory accuracy (p < 0.05) and decreased cognitive flexibility accuracy (p < 0.05).

Solianik R, Sujeta A, Čekanauskaitė A Exp Brain Res, 2018. PMID 29860630

2018 / Double-blind, placebo-controlled randomized trial

A combination of hibiscus and lemon verbena polyphenols improved anthropometric measurements, lowered blood pressure, and modulated appetite hormones.

A double-blind, placebo-controlled trial evaluated a dietary supplement combining Lippia citriodora and Hibiscus sabdariffa polyphenolic extracts over 60 days in 54 overweight participants. Results showed improvements in anthropometric measurements, reductions in blood pressure and heart rate, and improved subjective health status. Furthermore, the extract combination increased the anorexigenic hormone glucagon-like peptide-1 and decreased the orexigenic hormone ghrelin.

Boix-Castejón M, Herranz-López M, Pérez Gago A, et al. Food Funct, 2018. PMID 29862395

2018 / Secondary analysis of two trials

Women following intermittent energy restriction showed spontaneous reductions in reported energy intake on unrestricted days.

Researchers analyzed self-reported food records from two trials of intermittent energy restriction (IER) in women (44 women for 6 months and 72 women for 4 months) to evaluate energy intake on unrestricted days. In both studies, reported energy intake on unrestricted days was 19% lower than the allocated isoenergetic diet, and 21% (Study 1) and 29% (Study 2) lower than baseline reported daily intakes, with similar reductions immediately before, after, and on other unrestricted days. Combined 3-month percentage weight loss was -5.8% (-6.7 to -4.7%) in those with consistent restriction days versus -7.4% (-8.7 to -6.2%) in the non-consistent group (p = .09). The authors noted that these findings need confirmation in larger groups, ideally using objective measures of energy balance.

Harvey J, Howell A, Morris J, et al. Food Sci Nutr, 2018. PMID 29876119

2018 / Randomized controlled trial

Energy compensation was similar between 1,500 and 3,000 kcal/week of exercise, but 3,000 kcal/week was sufficient to decrease body fat.

Thirty-six overweight-to-obese sedentary adults were randomized to exercise expending 300 or 600 kcal/session, 5 days/week for 12 weeks (1,500 vs. 3,000 kcal/week). The 3,000 kcal/week group significantly decreased percentage and kilograms of body fat (P < 0.01), whereas the 1,500 kcal/week group did not. The 1,500 and 3,000 kcal/week groups compensated for 943 (95% CI: -164 to 2,050) and 1,007 (95% CI: 32 to 1,982) kcal/week (62.9% and 33.6% of exercise energy expenditure, respectively; P >= 0.93 between groups). Resting metabolic rate and energy intake did not change, while food reinforcement and glucagon-like peptide-1 decreased (P < 0.02) and acylated ghrelin increased (P <= 0.02).

Flack KD, Ufholz K, Johnson L, et al. Am J Physiol Regul Integr Comp Physiol, 2018. PMID 29897822

2018 / Controlled pilot trial

A 12-week ketogenic diet reduced fat mass and increased LDL cholesterol without affecting performance metrics in CrossFit trainees.

Twelve CrossFit trainees were divided into a ketogenic diet group (n = 7) or a normal-diet control group (n = 5) for 12 weeks while continuing their training. Blood beta-hydroxybutyrate levels were 2.8- to 9.5-fold higher in the ketogenic group, confirming nutritional ketosis. In the ketogenic group, DXA fat mass decreased by 12.4% (p = 0.053), vastus lateralis thickness decreased by ~8% (p = 0.065), and dual-leg lean mass decreased by 1.4% (p = 0.068), while LDL cholesterol increased by ~35% (p = 0.048). No significant between-group differences were found for total lean body mass, fasting glucose, HDL cholesterol, triglycerides, resting energy expenditure, 1-RM back squat, 400 m run times, or VO2peak.

Kephart WC, Pledge CD, Roberson PA, et al. Sports (Basel), 2018. PMID 29910305

2018 / Intervention trial with matched historical controls

An 8-hour time-restricted feeding regimen reduced body weight, energy intake, and systolic blood pressure in obese adults compared to historical controls.

Obese participants (n = 23) adhered to an 8-h time-restricted feeding regimen (ad libitum feeding 10:00 to 18:00 h, water fasting 18:00 to 10:00 h) for 12 weeks, compared against 23 matched historical controls. Over 12 weeks, body weight decreased by -2.6% ± 0.5 and energy intake by -341 ± 53 kcal/d relative to controls (P < 0.05). Systolic blood pressure also fell (-7 ± 2 mm Hg vs controls, P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine did not differ significantly between groups.

Gabel K, Hoddy KK, Haggerty N, et al. Nutr Healthy Aging, 2018. PMID 29951594

2018 / Randomized controlled trial

Ketogenic diet reduced fat mass but did not increase muscle during resistance training.

In an eight-week resistance training trial with caloric surplus, men consuming a ketogenic diet showed reduced fat mass (-0.8 kg, 95% CI -1.6 to -0.1) and visceral adipose tissue (-96.5 g, 95% CI -159.0 to -34.0). Neither total weight nor muscle mass increased significantly in the ketogenic group. Conversely, the non-ketogenic diet group gained both body weight (0.9 kg) and muscle mass (1.3 kg, 95% CI 0.5 to 2.2).

Vargas S, Romance R, Petro JL, et al. J Int Soc Sports Nutr, 2018. PMID 29986720

2018 / Randomized, placebo-controlled, double-blind parallel trial

In obese, insulin-resistant men, 12 weeks of nicotinamide riboside supplementation was safe but did not improve insulin sensitivity or glucose metabolism.

Forty sedentary, obese men aged 40-70 years were randomized to receive 12 weeks of nicotinamide riboside (NR, 1000 mg twice daily) or placebo. NR supplementation did not improve insulin sensitivity, endogenous glucose production, glucose disposal, or glucose oxidation. Furthermore, NR had no effect on resting energy expenditure, lipolysis, lipid oxidation, or body composition. No serious adverse events occurred and safety blood tests remained normal.

Dollerup OL, Christensen B, Svart M, et al. Am J Clin Nutr, 2018. PMID 29992272

2018 / Randomized controlled trial

Baru almond consumption reduced waist circumference and increased HDL in overweight and obese women.

A trial randomized 46 overweight and obese women to an isoenergetic diet either supplemented with or free of baru almonds for 8 weeks. Compared with the control diet, consuming baru almonds reduced waist circumference by 2.45 cm (95% CI, -3.90 to -0.23; P = 0.03) and cholesteryl ester transfer protein expression by 0.23 mcg/mL (95% CI, -1.24 to -0.08; P = 0.03). High-density lipoprotein concentrations also increased by 4.82 mg/dL (95% CI, 0.03 to 8.88; P = 0.04).

de Souza RGM, Gomes AC, de Castro IA, et al. Nutrition, 2018. PMID 30086484

2018 / Randomized 3x3 crossover trial

Adding Hass avocado to a meal lowered 3-hour GLP-1 AUC compared to control in overweight adults, while gut hormones correlated with appetite scores.

A randomized 3x3 crossover study in 26 healthy overweight adults evaluated gut hormone responses and appetite sensations across three lunch test meals consumed one week apart: control, isoenergic avocado inclusive, and energy increased avocado added (AA). A decrease in the 3-hour GLP-1 area under the curve was observed with the AA meal compared to the control meal (P = 0.03). Across meals, PYY3-36 and GIP were negatively associated with hunger, desire, and amount to eat, and positively associated with fullness, satisfaction, and composite visual analog scale (VAS) score (all P < 0.001). GLP-1 was negatively associated with hunger and positively associated with satisfaction and composite VAS score (all P < 0.05).

Haddad E, Wien M, Oda K, et al. Eat Behav, 2018. PMID 30096700

2018 / Randomized controlled trial

One night of sleep loss was accompanied by tissue-specific changes in DNA methylation, transcriptomics, and metabolism in human adipose tissue and muscle.

Researchers analyzed adipose tissue and skeletal muscle obtained from humans after one night of sleep loss and after one full night of sleep. Acute sleep loss was found to alter genome-wide DNA methylation in adipose tissue, along with tissue-specific transcriptomic, protein, and metabolite changes partially reflected in blood. Inflammation signatures were observed in both tissues, whereas circadian clock alterations were detected only in skeletal muscle alongside molecular signatures suggestive of muscle breakdown contrasting with an anabolic adipose tissue signature.

Cedernaes J, Schönke M, Westholm JO, et al. Sci Adv, 2018. PMID 30140739

2018 / Randomized controlled trial

A low-carbohydrate diet combined with HIIT yielded the greatest percentage improvements in glucose, cholesterol, weight, and several inflammatory markers in obese T2D patients.

Researchers randomized inactive obese patients with type 2 diabetes into three experimental diet groups (low-carbohydrate [LCD], low-fat [LFD], high-fat [HFD]; n=11 each) and a normal diet control group (n=9) over 24 weeks combining diets with 12 weeks of cycle-ergometer HIIT. After 24 weeks, the highest percentage improvements were seen in LCD for glucose (-34.76%), cholesterol (-33.35%), HDL (+41.81%), triglycerides (-40.71%), and weight (-12.49%). The highest percentage reductions in IL-6 (-32.10%), resistin (-28.29%), and leptin (-53.92%) occurred in the LCD group, while LFD showed the largest improvements in TNF-alpha (-48.06%), FGF21 (+55.30%), and adiponectin (+42.32%).

Asle Mohammadi Zadeh M, Kargarfard M, Marandi SM, et al. J Diabetes Metab Disord, 2018. PMID 30918861